An Obscure Natural NAD + -Boosting Sirtuin Activator: N 1 -Methylnicotinamide (1-MNA)

From the paper

Abstract

N 1-Methylnicotinamide (1-MNA)-a quaternary pyridinium derivative of vitamin B3-emerges as a largely unstudied, naturally occurring molecule with significant anti-ageing potential. Trace amounts (≤ 3 mg • 100 g −1 dry weight) are found in select plants such as brown seaweed (Undaria pinnatifida), green tea leaves, shiitake mushrooms, and celery, yet the compound remains virtually absent from mainstream biomedical literature. Unlike widely used NAD + boosters (e.g., NMN, NR), 1-MNA operates through a dual mechanism: (i) feedback inhibition of nicotinamide N-methyltransferase (NNMT) conserves nicotinamide for the NAD + salvage pathway, elevating intracellular NAD + levels; and (ii) direct stabilisation and up-regulation of SIRT1 protein relieves nicotinamide-mediated inhibition, amplifying sirtuin activity. Pre-clinical data indicate additional vasoprotective and mitohormetic effects that synergistically enhance metabolic and longevity pathways. Early animal and limited human studies report physiological benefits at doses an order of magnitude lower than those typically required for NMN, suggesting superior bioavailability and potency. Nevertheless, 1-MNA remains obscure due to its minute natural abundance, challenging chemical synthesis, and lack of commercial development. Collectively, these attributes position 1-MNA as a compelling but under-explored candidate for next-generation NAD + /sirtuin-targeted therapeutics and warrant comprehensive investigation into its pharmacokinetics, safety, and comparative efficacy against established NAD + precursors.